AlphaMark Advisors »

Aligos Therapeutics shares owned by AlphaMark Advisors

Quarter-by-quarter ownership of Aligos Therapeutics shares owned by AlphaMark Advisors from 13F filings

Historical chart of AlphaMark Advisors investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by AlphaMark Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by AlphaMark Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.0k 100 10.00

More positions owned by AlphaMark Advisors

AlphaMark Actively Man Etf (SMCP)
iShares S&P 500 Index (IVV)
Health Care SPDR (XLV)
Technology SPDR Etf (XLK)
SPDR Trust Unit SR Etf (SPY)
Procter & Gamble Company (PG)
Sch Fnd Em Lg Etf schb fdt emk lg (FNDE)
Db-x Msci Eafe Currency-hedged (DBEF)
First Tr Exchng Traded Fd Vi tcw opportunis (FIXD)
Financial Select Sector SPDR (XLF)
Industrial SPDR (XLI)
Janus Detroit Str Tr (JAAA)
Select Sector Spdr Tr Communic etfeqty (XLC)
Energy Select Sector SPDR (XLE)
Consumer Staples Select Sect. SPDR (XLP)

View all positions for AlphaMark Advisors

Top funds holding Aligos Therapeutics

Woodline Partners
Baker Bros. Advisors
Hillhouse Capital Advisors
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
Charles Schwab Investment Management
BlackRock
Bank of America Corporation
CWM
Advisor Group Holdings
AlphaMark Advisors
Jpmorgan Chase & Co
Zrc Wealth Management
Bnp Paribas Arbitrage, Snc

View all funds holding Aligos Therapeutics